Researchers are studying a valuable target in regulating the immune response in cancer and autoimmunity. VISTA is a tempering molecule that hinders T cells in the immune system from activating against self-antigens such as cancer cells. Their new publication describes how VISTA controls T-cell responses.
from Top Health News -- ScienceDaily https://ift.tt/35W4nC5
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
During the Great Depression, Texans were put to work as fossil hunters. The workers retrieved tens of thousands of specimens that have been ...
-
Heart failure patients who consume more dietary fiber tend to have healthier gut bacteria, which is associated with reduced risk of death or...
-
The IT major further said the Ebit margin for the current quarter is expected to be between 20.5-21 per cent from Home Page https://ift.tt...
No comments:
Post a Comment